Schmidt M, Kimmig R
Klinik fur Gynakologie und Geburtshilfe, Universitatsklinikum Essen, Essen, Deutschland.
Gynakol Geburtshilfliche Rundsch. 2006;46(4):166-73. doi: 10.1159/000095725.
Hormonal replacement therapy (HRT) with estrogens and gestagens has been used for more than 40 years in the treatment of menopausal complaints and can be considered an effective treatment for vaso-vegetative symptoms and urogenital atrophy. During the past few years many women and doctors have revised their opinions of HRT. The reasons for this change of view are mainly three large international studies: the Heart and Estrogen/Progestin Study, the Women's Health Initiative Study and the One Million Women Study. In this review we summarize the data from the most important studies and point out the actual status of the controversial discussion on the benefits and risks of HRT.
雌激素和孕激素的激素替代疗法(HRT)已用于治疗更年期不适40多年,可被视为治疗血管舒缩症状和泌尿生殖系统萎缩的有效方法。在过去几年中,许多女性和医生对HRT的看法发生了改变。这种观点转变的主要原因是三项大型国际研究:心脏与雌激素/孕激素研究、妇女健康倡议研究和百万妇女研究。在本综述中,我们总结了最重要研究的数据,并指出了关于HRT利弊的争议性讨论的实际状况。